From RESEARCH to Clinical Practice edited by Patrick W. Serruys and Pedro A. Lemos
Recently, sirolimus-eluting stents implantation has been shown to decrease restenosis markedly in selected patients.
Nonetheless, the effects of SES implantation in complex, unselected patients, such as those commonly treated in daily practice ('the real world'), remains largely unknown.
Sirolimus-Eluting Stents comprehensively evaluates the impact of SES implantation on the outcomes of patients treated in the real world of interventional cardiology.
Sirolimus-Eluting Stents evaluates in detail the short- and long-term outcomes of several high-risk subsets not currently included in randomized trials.
While it is specific to sirolimus, Sirolimus-Eluting Stents covers the major competing drug eluting stents, including paclitaxel.
Contents:
Sirolimus-Eluting Stents for Patients at High Clinical Risk
Sirolimus-Eluting Stents for Patients at Special Anatomic Groups
to see books • videos • cd-roms of related interest
|
